Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Triple combination of interferon beta-1b, lopinavir–riton... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
0
Authors
Ivan Hung
55 more
Ivan Hung
•
Eugene Tso
53 more
•
Kwok-Yung Yuen
Published
May 1, 2020
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Medicine
Epidemiology
Internal Medicine
Gastroenterology
Infectious Diseases
Show all topics
DOI
10.1016/s0140-6736(20)31042-4
License
other-oa
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Medicine
Epidemiology
Internal Medicine
Gastroenterology
Infectious Diseases
Show all topics
DOI
10.1016/s0140-6736(20)31042-4
License
other-oa
